Title: AnGes MG Inc.Product Pipeline 2014: Big Market Research
1AnGes MG, Inc. - Product Pipeline Review -
2014 www.bigmarketresearch.com
2Acquired (Autoimmune) Hemolytic Anemia
Report Description
Summary Global Markets Directs, AnGes MG,
Inc. - Product Pipeline Review - 2014, provides
an overview of the AnGes MG, Inc.s
pharmaceutical research and development
focus. This report provides comprehensive
information on the current therapeutic
developmental pipeline of AnGes MG, Inc.s,
complete with comparative analysis at various
stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of
administration (RoA) and molecule type. It also
reviews latest updates, and featured news and
press releases, along with special features on
late-stage and discontinued projects. Get More
Details At http//www.bigmarketresearch.com/anges
-mg-inc-product-pipeline-review-2014-market
3Report Description
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team.
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease.
4Report Description
- Scope
- - The report provides brief overview of AnGes MG,
Inc. including business description, key
information and facts, and its locations and
subsidiaries - - The report reviews current pipeline of AnGes
MG, Inc.s human therapeutic division and enlists
all their major and minor projects - - The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones - - Special feature on out-licensed and partnered
product portfolio - - The report summarizes all the dormant and
discontinued pipeline projects - - Latest company statement
- - Latest news and deals relating to the AnGes MG,
Inc.s pipeline products - Enquire about report - http//www.bigmarketresearc
h.com/report-enquiry/152211
5Report Description
- Reasons to buy
- Evaluate AnGes MG, Inc.s strategic position with
total access to detailed information on its
product pipeline - Assess the growth potential of AnGes MG, Inc. in
its therapy areas of focus - Identify new drug targets and therapeutic classes
in the AnGes MG, Inc.s RD portfolio and develop
key strategic initiatives to reinforce pipeline
in those areas - Exploit in-licensing opportunities by identifying
windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding
the focus areas of AnGes MG, Inc. and exploit
collaboration and partnership opportunities
6Report Description
- Reasons to buy
- Identify emerging players with potentially strong
product portfolio and create effective
counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by
identifying the most promising pipeline of AnGes
MG, Inc. - Develop and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and scope - Explore the dormant and discontinued projects of
AnGes MG, Inc. and identify potential
opportunities in those areas - Avoid Intellectual Property Rights related issues
7Table Of Content
- List of Tables
- List of Figures
- AnGes MG, Inc. Snapshot
- AnGes MG, Inc. Overview
- Key Information
- Key Facts
- AnGes MG, Inc. - Research and Development
Overview - Key Therapeutic Areas
- AnGes MG, Inc. - Pipeline Review
- Pipeline Products by Stage of Development
- Pipeline Products - Monotherapy
- Pipeline Products - Partnered Products
- Get complete TOC here _at_ http//www.bigmarketresear
ch.com/anges-mg-inc-product-pipeline-review-2014-m
arket
8FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/anges-mg-inc-prod
uct-pipeline-review-2014-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (855) 711-1555E-MAIL
sales_at_bigmarketresearch.com